![Cancer treatments / Adjuvant therapy / Dysplastic nevus syndrome / Sentinel lymph node / Dacarbazine / DecisionDx-UM / Medicine / Oncology / Melanoma Cancer treatments / Adjuvant therapy / Dysplastic nevus syndrome / Sentinel lymph node / Dacarbazine / DecisionDx-UM / Medicine / Oncology / Melanoma](https://www.pdfsearch.io/img/2467df727e3d8fb515d63514a1b857f3.jpg) Date: 2012-05-01 11:12:36Cancer treatments Adjuvant therapy Dysplastic nevus syndrome Sentinel lymph node Dacarbazine DecisionDx-UM Medicine Oncology Melanoma | | ASCO Classic Oncology References Melanoma Epidemiology/Biology 1. Barnhill RL, Katzen J, Spatz A, et al The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol; 2005 Apr; 32Add to Reading ListSource URL: university.asco.orgDownload Document from Source Website File Size: 227,85 KBShare Document on Facebook
|